- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05735808
VR Education in Arterial Hypertension
A Pilot Study of the Feasibility and Non-inferiority of Patient Education About Arterial Hypertension in Virtual Reality
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
To demonstrate the technical and organizational feasibility of patient education about arterial hypertension in virtual reality. Demonstrate the non-inferiority of education conducted in virtual reality to traditional face-to-face education by a physician. To define the cost-effectiveness of education in virtual reality in the reality of progressing shortage of human resources.
Patients diagnosed with arterial hypertension as part of a routine examination in an internal medicine outpatient clinic will be randomized to education about the disease directly by a physician in one arm or using a 3D movie in VR glasses filmed by a physician in an identical outpatient clinic setting. It will be concluded by questionnaire method to compare the outcome of both education namely subjective satisfaction and objectively by using questions to evaluate the success of the education.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Bogna Jiravska Godula, MD
- Phone Number: +420602579193
- Email: Bogna.jiravska-godula@npo.agel.cz
Study Locations
-
-
-
Ostrava, Czechia
- Recruiting
- Poliklinika Agel
-
Contact:
- Bogna Jiravska Godula, MD
- Phone Number: +420724307894
- Email: bogna.jiravska-godula@npo.agel.cz
-
Contact:
- Otakar Jiravsky, MD
- Phone Number: +420602579193
- Email: otakar.jiravsky@npo.agel.cz
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- all consecutive patients with arterial hypertension
Exclusion Criteria:
- visual impairment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Standart physicain based education
In this arm, patient education will be conducted by the physician as the gold standard.
|
Regular education provided by physician
|
|
Experimental: VR based education
In this arm, patient education will be performed using 3D educational material presented in VR glasses.
|
VR based education
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Non-Inferiority of VR augmented education: physician assessment of objective patient understanding
Time Frame: 18 months
|
After the education, the patient will answer a prepared list of questions on arterial hypertension whose answers were mentioned in the previous education and the percentage of correct/wrong answers will be compared in both arms of the study.
|
18 months
|
|
Non-Inferiority of VR augmented education:subjective evaluation of education by the patient
Time Frame: 18 months
|
After the education, the patient will rate how he/she subjectively perceived the subjective pleasantness of the education on a scale of 1 to 5 ( 1 best/ 5 worst).
|
18 months
|
Collaborators and Investigators
Investigators
- Study Chair: Otakar Jiravsky, Nemocnice AGEL Trinec-Podlesi a.s.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PAgel
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Arterial Hypertension
-
VIVUS LLCNot yet recruitingPulmonary Arterial Hypertension | Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH) | Pulmonary Arterial Hypertension (PAH) | Pulmonary Arterial Hypertension WHO Group I | Pulmonary Arterial Hypertension PAH
-
Rutgers, The State University of New JerseyRecruitingPulmonary Arterial Hypertension | Pulmonary Hypertension | Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH) | Pulmonary Arterial Hypertension of Congenital Heart Disease | Pulmonary Arterial Hypertension Associated With Schistosomiasis (Disorder) | Pulmonary Arterial and Chronic Thromboembolic... and other conditionsUnited States
-
Philipps University MarburgMSD Sharp & Dohme GmbH, GermanyNot yet recruiting
-
Stanford UniversityNational Heart, Lung, and Blood Institute (NHLBI); University of MichiganNot yet recruitingPulmonary Arterial Hypertension (PAH)United States
-
University of Sao Paulo General HospitalRecruitingPulmonary Arterial Hypertension (PAH)Brazil
-
University Hospital, BrestNot yet recruitingPulmonary Arterial Hypertension (PAH)France
-
Shanghai Zhongshan HospitalNot yet recruitingPulmonary Arterial Hypertension (PAH)
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
Regeneron PharmaceuticalsRecruitingPulmonary Arterial Hypertension (PAH)United States, United Kingdom, Latvia, South Korea
-
University of Sao Paulo General HospitalNot yet recruitingPulmonary Arterial Hypertension (PAH)Brazil
Clinical Trials on Physician based education
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedTreatment-Resistant HypertensionUnited States
-
Duke UniversityCompletedTreatment-Resistant HypertensionUnited States
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)CompletedCardiovascular Diseases | Coronary DiseaseUnited States
-
Oregon Health and Science UniversityCompletedObesity | Diabetes | Physical InactivityUnited States
-
University of PittsburghUPMC Office of Community InitiativesCompleted
-
Brigham and Women's HospitalRAND; Robert Wood Johnson FoundationCompletedHealth Knowledge, Attitudes, Practice | Health Care UtilizationUnited States
-
Cardenal Herrera UniversityNot yet recruitingPhysical Activity | Healthy Eating | Therapeutic Alliance | Glycemic Control for Diabetes Mellitus | Diabetes Mellitus (Type 2)Spain
-
Sheba Medical CenterCompletedTelemedicine | Emergency Care | Emergency Department CrowdingIsrael
-
Kaiser PermanenteAmerican Diabetes AssociationActive, not recruitingType 2 DiabetesUnited States
-
University of MichiganAgency for Healthcare Research and Quality (AHRQ)Completed